Data gathered: February 23
AI Stock Analysis - Bionano Genomics (BNGO)
Analysis generated January 4, 2025. Powered by Chat GPT.
Bionano Genomics (NASDAQ: BNGO) is a life sciences instrumentation company that develops and markets the Saphyr system. This advanced technology consists of DNA mapping software and is designed to help researchers and clinicians detect structural variations in a genome. This is especially useful in diagnosing complex conditions like genetic disorders and cancers. The company aims at revolutionizing cytogenetic diagnostics and offering significant improvements in the accuracy and efficiency of genome analysis.
Stock Alerts - Bionano Genomics (BNGO)
 |
Bionano Genomics | February 20 Price is down by -6.1% in the last 24h. |
|
Bionano Genomics | February 14 Price is up by 8.3% in the last 24h. |
|
Bionano Genomics | February 12 Price is down by -5.4% in the last 24h. |
|
Bionano Genomics | February 11 Price is up by 5.4% in the last 24h. |
Alternative Data for Bionano Genomics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1 | Sign up | Sign up | Sign up |
| Sentiment | 65 | Sign up | Sign up | Sign up |
| Webpage traffic | 22,000 | Sign up | Sign up | Sign up |
| Employee Rating | 50 | Sign up | Sign up | Sign up |
| Google Trends | 14 | Sign up | Sign up | Sign up |
| Patents | 23 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 2,180 | Sign up | Sign up | Sign up |
| Instagram Followers | 3,889 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 6 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 103,228 | Sign up | Sign up | Sign up |
| Twitter Mentions | 198 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 2,740 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | 22 | Sign up | Sign up | Sign up |
| Business Outlook | 6 | Sign up | Sign up | Sign up |
| Linkedin Employees | 181 | Sign up | Sign up | Sign up |
About Bionano Genomics
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight.
| Price | $5.36 |
| Target Price | Sign up |
| Volume | 78,650 |
| Market Cap | $12M |
| Year Range | $5 - $48.89 |
| Dividend Yield | 0% |
| PE Ratio | 0.03 |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
Bionano Genomics Announces $10 Million Registered Direct OfferingOn January 3, 2025, Bionano Genomics, Inc. (NASDAQ: BNGO) disclosed a definitive agreement with institutional investors for a registered direct offering. The offering involves the purchJanuary 7 - ETF Daily News |
|
Short Interest in Bionano Genomics, Inc. (NASDAQ:BNGO) Increases By 25.1%December 31 - ETF Daily News |
$1.81 Bn Optical Genome Mapping Market Global Forecasts 2024-2034 by Product and Services, Technique, Application, and End-UserJanuary 23 - GlobeNewswire |
|
Bionano Announces Effective Date of Reverse Stock SplitJanuary 22 - GlobeNewswire |
|
 |
Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy LossJanuary 14 - Investing.com |
|
Bionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Proven Therapy in Acute Promyelocytic LeukemiaJanuary 7 - Investing.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 6.1M | 43M | -37M | -44M | -44M | -0.268 |
| Q2 '24 | 12M | 17M | -5M | -16M | -17M | -0.220 |
| Q1 '24 | 8.4M | 26M | -18M | -31M | -31M | -0.510 |
| Q4 '23 | 5.9M | 31M | -25M | -44M | -32M | -0.959 |
| Q3 '23 | 9.2M | 109M | -99M | -113M | -112M | -1.000 |
Insider Transactions View All
| Mamuszka Hannah filed to buy 65,789 shares at $0.8. June 14 '23 |
| Holmlin R. Erik filed to buy 806,474 shares at $0.6. May 16 '23 |
| Stewart Christopher P. filed to buy 281,373 shares at $0.7. May 16 '23 |
| BARKER DAVID L filed to buy 13,894 shares at $1.6. May 18 '22 |
Similar companies
Read more about Bionano Genomics (BNGO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Bionano Genomics?
The Market Cap of Bionano Genomics is $12M.
What is Bionano Genomics' PE Ratio?
As of today, Bionano Genomics' PE (Price to Earnings) ratio is 0.03.
What is the current stock price of Bionano Genomics?
Currently, the price of one share of Bionano Genomics stock is $5.36.
How can I analyze the BNGO stock price chart for investment decisions?
The BNGO stock price chart above provides a comprehensive visual representation of Bionano Genomics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bionano Genomics shares. Our platform offers an up-to-date BNGO stock price chart, along with technical data analysis and alternative data insights.
Does BNGO offer dividends to its shareholders?
As of our latest update, Bionano Genomics (BNGO) does not offer dividends to its shareholders. Investors interested in Bionano Genomics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Bionano Genomics?
Some of the similar stocks of Bionano Genomics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.